Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
LeMaitre Vascular
LMAT
$1.86B
| $474K | ﹤0.01% |
4,942
-10,051
| -67% | -$1.03M |
|
3227
CytomX Therapeutics
CTMX
$588M
| $474K | ﹤0.01% |
126,415
-15,997
| -11% | -$61.1K |
|
3228
American Resources Corp
AREC
$203M
| $473K | ﹤0.01% |
220,211
+52,096
| +31% | +$116K |
|
3229
Aurinia Pharmaceuticals
AUPH
$2.19B
| $473K | ﹤0.01% |
27,892
-2,108
| -7% | -$33.7K |
|
|
GPGI
3230
GPGI Inc
GPGI
$3.37B
| $472K | ﹤0.01% |
29,793
-7,804
| -21% | -$112K |
|
3231
Ivanhoe Electric
IE
$1.69B
| $470K | ﹤0.01% |
48,921
+21,129
| +76% | +$267K |
|
3232
Immatics
IMTX
$1.27B
| $469K | ﹤0.01% |
46,265
-18,389
| -28% | -$194K |
|
3233
Energy Services of America
ESOA
$207M
| $467K | ﹤0.01% |
24,136
-5,682
| -19% | -$92.6K |
|
3234
First Community Bankshares
FCBC
$901M
| $467K | ﹤0.01% |
10,506
-1,207
| -10% | -$51.9K |
|
3235
Business First Bancshares
BFST
$1B
| $466K | ﹤0.01% |
15,163
+4,547
| +43% | +$128K |
|
3236
Pacific Biosciences
PACB
$504M
| $465K | ﹤0.01% |
276,988
+54,641
| +25% | +$79.4K |
|
|
MPLT
3237
MapLight Therapeutics
MPLT
$581M
| $465K | ﹤0.01% |
12,975
+7,186
| +124% | +$207K |
|
3238
Red River Bancshares
RRBI
$665M
| $463K | ﹤0.01% |
5,072
+3,943
| +349% | +$361K |
|
|
LBRDA
3239
DELISTED
Liberty Broadband Class A
LBRDA
| $463K | ﹤0.01% |
13,906
+8,233
| +145% | +$321K |
|
3240
Bausch Health
BHC
$2.13B
| $463K | ﹤0.01% |
93,864
-29,919
| -24% | -$161K |
|
3241
ZipRecruiter
ZIP
$289M
| $462K | ﹤0.01% |
123,202
-1,151
| -0.9% | -$3.57K |
|
3242
ArcelorMittal
MT
$53.2B
| $461K | ﹤0.01% |
7,648
-14,113
| -65% | -$883K |
|
3243
Unity Bancorp
UNTY
$563M
| $459K | ﹤0.01% |
7,819
-981
| -11% | -$53.5K |
|
3244
Real REMAX Group Inc. Common Stock
REAX
$358M
| $457K | ﹤0.01% |
25,117
+11,714
| +87% | +$238K |
|
3245
Allogene Therapeutics
ALLO
$570M
| $457K | ﹤0.01% |
219,718
+58,872
| +37% | +$129K |
|
3246
Natural Gas Services Group
NGS
$423M
| $456K | ﹤0.01% |
10,581
+1,169
| +12% | +$47.5K |
|
3247
Digi International
DGII
$2.97B
| $456K | ﹤0.01% |
6,086
-5,546
| -48% | -$344K |
|
3248
America Movil
AMX
$65.9B
| $453K | ﹤0.01% |
17,441
+16,476
| +1,707% | +$433K |
|
3249
Phathom Pharmaceuticals
PHAT
$591M
| $453K | ﹤0.01% |
41,777
+16,420
| +65% | +$187K |
|
3250
iShares ESG Aware MSCI USA ETF
ESGU
$18.2B
| $452K | ﹤0.01% |
2,762
| – | – |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.